Instituto Portugues de Oncologia, Francisco Gentil, Porto
With
Polytechnic Institute of Porto
VTT Technical Research Centre, Finland
University of Oulu
Linnaeus University
European Commission
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women
Aged 18 to 65
Diagnosed with breast, prostate, or colorectal cancer
Have been diagnosed with cancer stage I-III
Have finished cancer treatments from 3 months to 2 years (it will be included ongoing hormonal therapies)
Experiencing significant distress (5 or more) on the Distress Thermometer at baseline
Available to attend the intervention for the trial duration
Sufficient functional ability to participate in intervention groups (ECOG)
Ability to speak and write Portuguese and literacy to autonomous completion of questionnaires
You may not be if
Patients in treatments such as ongoing chemotherapy or radiotherapy, or trastuzumab therapy
Patients with ostomy
A diagnosis of a concurrent disorder of psychosis, substance abuse, bipolar disorder, or active suicidality
Current use of antipsychotics
Current use of anti-inflammatory medication (corticotherapy)
Currently engaging in a mindfulness meditation practice or yoga, or having done so within the previous year
Being under any actual psychosocial or psychological treatment
Participation in a MBCT program in the last five years
Pregnancy or breast feeding
A diagnosis of a concurrent autoimmune disorder
Study Population Description: Participants will be recruited in the Portuguese Oncology Institute of Porto (Porto, Portugal), which is a reference public hospital in the north of the country offering cancer treatments.
